Company Quick10K Filing
Fortem Resources
10-Q 2020-05-31 Filed 2020-07-21
10-K 2020-02-29 Filed 2020-07-21
10-Q 2019-11-30 Filed 2020-01-09
10-Q 2019-08-31 Filed 2019-10-30
10-Q 2019-05-31 Filed 2019-10-18
10-K 2019-02-28 Filed 2019-10-18
10-Q 2018-11-30 Filed 2019-01-09
10-Q 2018-08-31 Filed 2018-10-10
10-Q 2018-05-31 Filed 2018-07-16
10-K 2018-02-28 Filed 2018-06-28
10-Q 2017-11-30 Filed 2018-01-31
10-Q 2017-08-31 Filed 2017-10-17
10-Q 2017-05-31 Filed 2017-07-24
10-K 2017-02-28 Filed 2017-05-30
10-Q 2016-11-30 Filed 2017-01-17
10-Q 2016-08-31 Filed 2016-10-14
10-Q 2016-05-31 Filed 2016-07-15
10-K 2016-02-29 Filed 2016-06-13
10-Q 2015-11-30 Filed 2016-01-14
10-Q 2015-08-31 Filed 2015-10-20
10-Q 2015-05-31 Filed 2015-07-15
10-K 2015-02-28 Filed 2015-06-02
10-Q 2014-11-30 Filed 2015-01-14
10-Q 2014-08-31 Filed 2014-10-15
10-Q 2014-05-31 Filed 2014-07-15
10-K 2014-02-28 Filed 2014-05-29
10-Q 2013-11-30 Filed 2014-01-14
10-Q 2013-08-31 Filed 2013-10-15
10-K 2013-02-28 Filed 2013-06-14
10-Q 2012-11-30 Filed 2013-01-22
10-Q 2012-08-31 Filed 2012-10-15
10-Q 2012-05-31 Filed 2012-07-16
10-K 2012-02-29 Filed 2012-05-29
10-Q 2011-11-30 Filed 2012-01-17
8-K 2020-10-08 Officers
8-K 2020-05-28
8-K 2020-05-22
8-K 2019-09-19
8-K 2019-09-16
8-K 2019-08-08
8-K 2019-07-18
8-K 2019-07-11
8-K 2019-07-02
8-K 2019-06-28
8-K 2019-06-17
8-K 2019-05-30
8-K 2019-05-16
8-K 2019-03-14
8-K 2019-01-25
8-K 2018-12-17
8-K 2018-12-12
8-K 2018-12-10
8-K 2018-11-05
8-K 2018-10-16
8-K 2018-09-26
8-K 2018-09-21
8-K 2018-08-24
8-K 2018-08-21
8-K 2018-08-16
8-K 2018-07-26
8-K 2018-07-18
8-K 2018-06-14
8-K 2018-05-28
8-K 2018-03-27
8-K 2018-01-18
8-K 2018-01-17

Fortem Resources Financials

FTMR Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Exagen (XGN) 182,113 54% -60.9 -3% 92,744 34,094 10,439 5,656 -3,141 -2,132 129,862
Soliton (SOLY) 179,964 -14.9 -130% 9,927 2,745 0 0 -12,896 -11,529 171,255
Acro Biomedical (ACBM) 177,190 10% -1,443.4 -13% 1,081 133 3,760 388 -142 -123 177,189
Energy & Technology (ENGT) 177,150 32% -1,446.0 -4% 3,954 9,029 3,101 984 -143 -122 177,039
Kraig Biocraft Laboratories (KBLB) 176,366 -99.2 -224% 899 5,504 0 0 -2,009 -1,775 176,083
American BriVision (ABVC) 175,304 97% -71.6 -38% 7,405 6,675 602 584 -2,817 -2,434 174,252
Vaneck Merk Gold Trust (OUNZ) 175,193 8.4 12% 174,523 0 0 0 20,914 20,914 175,193
Invesco DB Gold Fund (DGL) 174,116 9.8 10% 174,089 3,964 0 0 17,743 17,748 174,116
Fulcrum Therapeutics (FULC) 173,470 -2.4 -26% 115,956 13,828 0 0 -29,711 -29,711 70,781
MariMed (MRMD) 172,389 39% 23.2 -2% 137,056 54,263 40,412 15,889 -2,498 9,162 212,127
Fortem Resources (FTMR) 191,211 -119.9 -1% 143,155 18,644 0 0 -1,741 -1,603 192,221
Cure Pharmaceutical (CURR) 171,305 94% -10.1 -60% 34,029 20,673 284 266 -20,482 -16,320 165,597
FC Global Realty (FCRE) 170,563 86% -62.4 -2% 134,314 52,885 44 38 -2,748 -2,732 170,584
Applied Therapeutics (APLT) 170,485 -5.6 -75% 37,264 6,517 0 0 -27,880 -27,880 157,420
SWK Holdings (SWKH) 167,159 0% 9.7 6% 247,535 19,907 21,396 0 15,043 16,831 162,673
DOCASA (DCSA) 166,631 24% -117.8 -8% 22,047 6,626 6,454 1,527 -1,773 -1,408 165,842
Jamba (JMBA) 165,009 0% 68.1 -4% 36,654 46,912 78,265 0 -1,563 2,289 155,914
QNB (QNBC) 162,260 5.6 1% 1,245,863 1,126,878 0 0 11,939 25,390 141,473
Diverse Development Group (DDG) 161,311 -3,433.4 -24,302% 0 174 0 0 -43 -47 161,311
Gold Reserve (GDRZF) 161,165 -8.9 -15% 78,340 104,144 0 0 -11,575 -11,575 103,488

Balance Sheet ($'000)2011-08-312011-11-302012-02-292012-05-312012-08-312012-11-302013-02-282013-05-312013-08-312013-11-302014-02-282014-05-312014-08-312014-11-302015-02-282015-05-312015-08-312016-02-292016-05-312016-08-312016-11-302017-02-282017-05-312017-08-312017-11-302018-02-282018-05-312018-08-312018-11-302019-02-282019-05-31
Cash117851203994927554326136827602222844596414610117714589603564
Accounts Receivable1211
Inventory
PP&E64636262616059676565615758575555535656555453527150
Assets521096641,9732,0911,5791,7271,5921,5101,0981,1141,0941,2067577637246917857557661,240227,139227,4384,3274,5504,5515,4627,892142,836143,155
Accounts Payable1,3107688231,0931,091
Long-Term Debt5001,074
Liabilities1211571844481,6121,8051,9921,8831,7781,6461,7391,8211,6561,1771,1461,1349751,3081,4791,2211,9303,02081,73283,7711,5171,7861,3121,0241,29118,03518,644
Stockholders' Equity-116-155-75216362286-413-156-186-136-614-707-56128-389-371-251-617-694-466-1,164-1,780145,407143,6672,8102,7643,2394,4386,601124,801124,510
Income Statement ($'000)2011-08-312011-11-302012-02-292012-05-312012-08-312012-11-302013-02-282013-05-312013-08-312013-11-302014-02-282014-05-312014-08-312014-11-302015-02-282015-05-312015-08-312016-02-292016-05-312016-08-312016-11-302017-02-282017-05-312017-08-312017-11-302018-02-282018-05-312018-08-312018-11-302019-02-282019-05-31
Revenue
Cost of Revenue
Gross Profit
R&D
SG&A-35-39476211380-9110828109725510374182226
Tax0000000000000
Net Income-35-39-113-211-130-126-730-393732-652-90-2746-28613106-134232-792-2,031-4,958-1,851-1,165-332-285-401-367-497-476
Cash Flow ($'000)2011-08-312011-11-302012-02-292012-05-312012-08-312012-11-302013-02-282013-05-312013-08-312013-11-302014-02-282014-05-312014-08-312014-11-302015-02-282015-05-312015-08-312016-02-292016-05-312016-08-312016-11-302017-02-282017-05-312017-08-312017-11-302018-02-282018-05-312018-08-312018-11-302019-02-282019-05-31
Cash Operating-12-94-374-43-957-233156-95-265-59-119-167-279-45-108-91-55-45-8-29975-41691-128-534-313-444
Cash Investing-111-632-139-97-1-155-8105-1-38-100119-3-7-53-1,898-41667266-155-180-191-185
Cash Financing1118245882613002912221875010930616130109104251343361,831333364-2821201,290479658